製品名:5-Amino-2-pyridinol hydrochloride
IUPAC Name:5-aminopyridin-2-ol hydrochloride
Product Overview |
5-Amino-2-pyridinol hydrochloride (5-AP2HCl) is a compound that is used in various scientific research applications. 5-AP2HCl is the hydrochloride salt of the 5-amino-2-pyridinol molecule, which is an organic compound comprised of an amino group, a pyridine ring, and two hydroxyl groups. It is a versatile compound that can be used in a variety of scientific research applications. |
Physical Properties |
It is a white, crystalline solid. |
Synthesis and Application |
5-Amino-2-pyridinol hydrochloride can be synthesized through a multi-step process. The first step involves the reaction of 5-aminopyridine and hydrochloric acid in aqueous solution. This reaction forms 5-aminopyridine hydrochloride, which is then reacted with sodium hydroxide and ethanol to form 5-Amino-2-pyridinol hydrochloride. The reaction is carried out at a temperature of 70°C for about three hours. 5-Amino-2-pyridinol hydrochloride is used in a variety of scientific research applications, such as in the study of enzyme inhibition, protein-protein interactions, and drug metabolism. It has also been used in the study of the metabolism of drugs, such as the antiretroviral drug efavirenz. 5-Amino-2-pyridinol hydrochloride has also been used to study the inhibition of the enzyme cyclooxygenase-2, which is involved in the production of prostaglandins. |
Future Directions |
There are a number of potential future directions for the use of 5-Amino-2-pyridinol hydrochloride. One potential direction is to develop more efficient methods for synthesizing the compound, as well as methods for increasing its solubility. It could also be used in the development of new drugs and drug delivery systems. Additionally, it could be used in the study of the inhibition of other enzymes and proteins, as well as in the study of the metabolism of other drugs. Finally, it could be used in the development of new treatments for diseases, such as cancer and Alzheimer's disease. |